AMNEAL PHARMACEUTICALS, INC. Basic Shares Outstanding (Weighted Average)
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Basic Shares Outstanding (Weighted Average) of 319.20 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- AMNEAL PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 319.20M shares, a 1.74% increase year-over-year.
- AMNEAL PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 316.02M shares, a 1.60% increase year-over-year.
- AMNEAL PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 314.47M shares, a 1.49% increase year-over-year.
- AMNEAL PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 314.17M shares, a 1.46% increase year-over-year.
- AMNEAL PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 313.37M shares, a 1.42% increase from fiscal 2024.
- AMNEAL PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 308.98M shares, a 75.42% increase from fiscal 2023.
- AMNEAL PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 176.14M shares, a 16.69% increase from fiscal 2022.
- AMNEAL PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 150.94M shares, a 1.36% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 319.20M shares 10-Q · filed 2026-08-06 | 317.62M shares 10-Q · filed 2026-08-06 | 316.57M shares derived: average of 3 quarters · filed 2026-08-06 | 315.97M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 316.02M shares 10-Q · filed 2026-05-07 | 315.25M shares derived: average of 2 quarters · filed 2026-05-07 | 314.89M shares derived: average of 3 quarters · filed 2026-05-07 | 314.60M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 314.47M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 314.32M shares derived: average of 2 quarters · filed 2026-02-27 | 314.13M shares derived: average of 3 quarters · filed 2026-08-06 | 313.37M shares 10-K · filed 2026-02-27 |
| 2025-09-30 | 314.17M shares 10-Q · filed 2025-11-06 | 313.95M shares derived: average of 2 quarters · filed 2026-08-06 | 313.00M shares 10-Q · filed 2025-11-06 | 312.20M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 313.74M shares 10-Q · filed 2026-08-06 | 312.40M shares 10-Q · filed 2026-08-06 | 311.55M shares derived: average of 3 quarters · filed 2026-08-06 | 311.07M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 311.05M shares 10-Q · filed 2026-05-07 | 310.46M shares derived: average of 2 quarters · filed 2026-05-07 | 310.19M shares derived: average of 3 quarters · filed 2026-05-07 | 309.92M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 309.86M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 309.75M shares derived: average of 2 quarters · filed 2026-02-27 | 309.54M shares derived: average of 3 quarters · filed 2026-02-27 | 308.98M shares 10-K · filed 2026-02-27 |
| 2024-09-30 | 309.65M shares 10-Q · filed 2025-11-06 | 309.38M shares derived: average of 2 quarters · filed 2025-11-06 | 308.69M shares 10-Q · filed 2025-11-06 | 292.62M shares derived: average of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | 309.12M shares 10-Q · filed 2025-08-07 | 308.20M shares 10-Q · filed 2025-08-07 | 286.95M shares derived: average of 3 quarters · filed 2026-02-27 | 253.77M shares derived: average of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | 307.28M shares 10-Q · filed 2025-05-07 | 275.87M shares derived: average of 2 quarters · filed 2026-02-27 | 235.32M shares derived: average of 3 quarters · filed 2026-02-27 | 214.92M shares derived: average of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | 244.46M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 199.34M shares derived: average of 2 quarters · filed 2026-02-27 | 184.14M shares derived: average of 3 quarters · filed 2026-02-27 | 176.14M shares 10-K · filed 2026-02-27 |
| 2023-09-30 | 154.22M shares 10-Q · filed 2024-11-12 | 153.98M shares derived: average of 2 quarters · filed 2024-11-12 | 153.36M shares 10-Q · filed 2024-11-12 | 152.89M shares derived: average of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | 153.74M shares 10-Q · filed 2024-08-09 | 152.93M shares 10-Q · filed 2024-08-09 | 152.44M shares derived: average of 3 quarters · filed 2025-02-28 | 152.18M shares derived: average of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | 152.11M shares 10-Q · filed 2024-05-08 | 151.79M shares derived: average of 2 quarters · filed 2025-02-28 | 151.66M shares derived: average of 3 quarters · filed 2025-02-28 | 151.49M shares derived: average of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | 151.48M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | 151.44M shares derived: average of 2 quarters · filed 2025-02-28 | 151.29M shares derived: average of 3 quarters · filed 2025-02-28 | 150.94M shares 10-K · filed 2025-02-28 |
| 2022-09-30 | 151.39M shares 10-Q · filed 2023-11-09 | 151.19M shares derived: average of 2 quarters · filed 2023-11-09 | 150.76M shares 10-Q · filed 2023-11-09 | 150.41M shares derived: average of 4 quarters · filed 2024-03-14 |
| 2022-06-30 | 150.99M shares 10-Q · filed 2023-08-08 | 150.44M shares 10-Q · filed 2023-08-08 | 150.09M shares derived: average of 3 quarters · filed 2024-03-14 | 149.89M shares derived: average of 4 quarters · filed 2024-03-14 |
| 2022-03-31 | 149.89M shares 10-Q · filed 2023-05-09 | 149.63M shares derived: average of 2 quarters · filed 2024-03-14 | 149.52M shares derived: average of 3 quarters · filed 2024-03-14 | 149.39M shares derived: average of 4 quarters · filed 2024-03-14 |
| 2021-12-31 | 149.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | 149.33M shares derived: average of 2 quarters · filed 2024-03-14 | 149.22M shares derived: average of 3 quarters · filed 2024-03-14 | 148.92M shares 10-K · filed 2024-03-14 |
| 2021-09-30 | 149.29M shares 10-Q · filed 2022-11-07 | 149.14M shares derived: average of 2 quarters · filed 2022-11-07 | 148.77M shares 10-Q · filed 2022-11-07 | 148.49M shares derived: average of 4 quarters · filed 2023-03-03 |
| 2021-06-30 | 149.00M shares 10-Q · filed 2022-08-08 | 148.51M shares 10-Q · filed 2022-08-08 | 148.22M shares derived: average of 3 quarters · filed 2023-03-03 | 148.05M shares derived: average of 4 quarters · filed 2023-03-03 |
| 2021-03-31 | 148.01M shares 10-Q · filed 2022-05-06 | 147.83M shares derived: average of 2 quarters · filed 2023-03-03 | 147.74M shares derived: average of 3 quarters · filed 2023-03-03 | 147.65M shares derived: average of 4 quarters · filed 2023-03-03 |
| 2020-12-31 | 147.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | 147.60M shares derived: average of 2 quarters · filed 2023-03-03 | 147.53M shares derived: average of 3 quarters · filed 2023-03-03 | 147.44M shares 10-K · filed 2023-03-03 |
| 2020-09-30 | 147.56M shares 10-Q · filed 2021-11-08 | 147.47M shares derived: average of 2 quarters · filed 2021-11-08 | 147.38M shares 10-Q · filed 2021-11-08 | 146.02M shares derived: average of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | 147.39M shares 10-Q · filed 2021-08-09 | 147.29M shares 10-Q · filed 2021-08-09 | 145.51M shares derived: average of 3 quarters · filed 2022-03-01 | 141.81M shares derived: average of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | 147.18M shares 10-Q · filed 2021-05-07 | 144.57M shares derived: average of 2 quarters · filed 2022-03-01 | 139.96M shares derived: average of 3 quarters · filed 2022-03-01 | 136.97M shares derived: average of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | 141.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 136.34M shares derived: average of 2 quarters · filed 2022-03-01 | 133.57M shares derived: average of 3 quarters · filed 2022-03-01 | 132.11M shares 10-K · filed 2022-03-01 |
| 2019-09-30 | 130.73M shares 10-Q · filed 2020-11-06 | 129.37M shares derived: average of 2 quarters · filed 2020-11-06 | 128.82M shares 10-Q · filed 2020-11-06 | 128.46M shares derived: average of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | 128.02M shares 10-Q · filed 2020-08-06 | 127.85M shares 10-Q · filed 2020-08-06 | 127.71M shares derived: average of 3 quarters · filed 2021-03-01 | 127.59M shares derived: average of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | 127.69M shares 10-Q · filed 2020-05-11 | 127.55M shares derived: average of 2 quarters · filed 2021-03-01 | 127.45M shares derived: average of 3 quarters · filed 2021-03-01 | |
| 2018-12-31 | 127.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 127.33M shares derived: average of 2 quarters · filed 2021-03-01 | 127.25M shares 10-K · filed 2021-03-01 | |
| 2018-09-30 | 127.25M shares 10-Q · filed 2019-11-07 | 127.20M shares 10-Q · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |